IRIS Accounts Production v24.3.0.553 14937832 Board of Directors Board of Directors 1.7.24 31.12.24 31.12.24 false true false false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh149378322024-06-30149378322024-12-31149378322024-07-012024-12-31149378322023-06-14149378322023-06-152024-06-30149378322024-06-3014937832ns15:EnglandWales2024-07-012024-12-3114937832ns14:PoundSterling2024-07-012024-12-3114937832ns10:Director12024-07-012024-12-3114937832ns10:Director22024-07-012024-12-3114937832ns10:PrivateLimitedCompanyLtd2024-07-012024-12-3114937832ns10:SmallEntities2024-07-012024-12-3114937832ns10:AuditExemptWithAccountantsReport2024-07-012024-12-3114937832ns10:SmallCompaniesRegimeForDirectorsReport2024-07-012024-12-3114937832ns10:SmallCompaniesRegimeForAccounts2024-07-012024-12-3114937832ns10:FullAccounts2024-07-012024-12-311493783212024-07-012024-12-3114937832ns10:OrdinaryShareClass12024-07-012024-12-3114937832ns10:RegisteredOffice2024-07-012024-12-3114937832ns5:CurrentFinancialInstruments2024-12-3114937832ns5:CurrentFinancialInstruments2024-06-3014937832ns5:Non-currentFinancialInstruments2024-12-3114937832ns5:Non-currentFinancialInstruments2024-06-3014937832ns5:ShareCapital2024-12-3114937832ns5:ShareCapital2024-06-3014937832ns5:RetainedEarningsAccumulatedLosses2024-12-3114937832ns5:RetainedEarningsAccumulatedLosses2024-06-3014937832ns5:IntangibleAssetsOtherThanGoodwill2024-07-012024-12-3114937832ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-07-012024-12-3114937832ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-06-3014937832ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3114937832ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-06-3014937832ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3114937832ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3014937832ns5:Non-currentFinancialInstruments2024-07-012024-12-3114937832ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3114937832ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-06-3014937832ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 14937832 (England and Wales)















Unaudited Financial Statements

for the Period 1 July 2024 to 31 December 2024

for

Vitae Life Limited

Vitae Life Limited (Registered number: 14937832)






Contents of the Financial Statements
for the Period 1 July 2024 to 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 7

Vitae Life Limited

Company Information
for the Period 1 July 2024 to 31 December 2024







DIRECTORS: Mrs S Angarano
M S S Soliman





REGISTERED OFFICE: 57-63
Knightsbridge
London
SW1X 7BF





REGISTERED NUMBER: 14937832 (England and Wales)





ACCOUNTANTS: The Peek Partnership Ltd
Unit 1,
Chancerygate Business Centre
Stonefiled Way
Ruislip
Middlesex
HA4 0JA

Vitae Life Limited (Registered number: 14937832)

Balance Sheet
31 December 2024

31/12/24 30/6/24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 93,146

CURRENT ASSETS
Stocks 106,560 95,984
Debtors 5 77,957 73,921
Cash at bank 996 74,823
185,513 244,728
CREDITORS
Amounts falling due within one year 6 1,072 73,368
NET CURRENT ASSETS 184,441 171,360
TOTAL ASSETS LESS CURRENT
LIABILITIES

184,441

264,506

CREDITORS
Amounts falling due after more than
one year

7

707,469

615,409
NET LIABILITIES (523,028 ) (350,903 )

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings (523,029 ) (350,904 )
SHAREHOLDERS' FUNDS (523,028 ) (350,903 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Vitae Life Limited (Registered number: 14937832)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 December 2025 and were signed on its behalf by:




Mrs S Angarano - Director



M S S Soliman - Director


Vitae Life Limited (Registered number: 14937832)

Notes to the Financial Statements
for the Period 1 July 2024 to 31 December 2024

1. STATUTORY INFORMATION

Vitae Life Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of three years.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Vitae Life Limited (Registered number: 14937832)

Notes to the Financial Statements - continued
for the Period 1 July 2024 to 31 December 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The Directors of the company have a reasonable assurance from the shareholders that the
company will continue to receive financial support to provide adequate resources to continue in
its operational existence for foreseeable future, being at least 12 months from the date of
signing this financial statement.
On this basis, the financial statement have been prepared on a going concern basis, which
assumes the company will be able to meet its liabilities as and when they fall due for the
foreseeable future. As of 31st December 2024, the company has net current assets of
£184,441 and net liabilities of £451,470. Which includes a shareholder's loan of £707,469
from its immediate parent company as well as (if applicable) non-current liabilities owed to the shareholders of the parent company.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2024 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Developme
costs
£   
COST
At 1 July 2024
and 31 December 2024 139,907
AMORTISATION
At 1 July 2024 46,761
Amortisation for period 93,146
At 31 December 2024 139,907
NET BOOK VALUE
At 31 December 2024 -
At 30 June 2024 93,146

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 30/6/24
£    £   
Trade debtors 18,881 18,881
Other debtors 59,076 55,040
77,957 73,921

Vitae Life Limited (Registered number: 14937832)

Notes to the Financial Statements - continued
for the Period 1 July 2024 to 31 December 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 30/6/24
£    £   
Trade creditors - 70,700
Taxation and social security 1,072 2,668
1,072 73,368

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31/12/24 30/6/24
£    £   
Other creditors 707,469 615,409

Included within creditors due after one year is an amount of £707,469 (2023: £615,409) owed to Advitam Wellness Ltd, a company owned by shareholder Mrs K Binani.

Of this balance, £500,000 relates to a convertible loan, which will be converted into ordinary shares of the company upon satisfaction of the agreed conversion conditions.

8. LOANS

An analysis of the maturity of loans is given below:

31/12/24 30/6/24
£    £   
Amounts falling due between two and five years:
Other loans - 2-5 years 707,469 615,409

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31/12/24 30/6/24
value: £    £   
100 Ordinary 0.01 1 1

10. RELATED PARTY DISCLOSURES

Other Creditors includes £707,469 owes to ultimate parent company Advitam Wellness Ltd, a company incorporated in England and Wales

Vitae Life Limited

Report of the Accountants to the Directors of
Vitae Life Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the period ended 31 December 2024 set out on pages one to eight and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






The Peek Partnership Ltd
Unit 1,
Chancerygate Business Centre
Stonefiled Way
Ruislip
Middlesex
HA4 0JA


Date: .............................................